SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/63491"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/63491" > Survival of patient...

Survival of patients with kyphoscoliosis receiving mechanical ventilation or oxygen at home

Gustafson, T. (författare)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Franklin, Karl (författare)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Midgren, B. (författare)
visa fler...
Pehrsson, Kerstin (författare)
Lund University,Lunds universitet,Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin,Institute of Medicine, Department of Internal Medicine,Lungmedicin, allergologi och palliativ medicin,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Respiratory Medicine, Allergology, and Palliative Medicine,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine
Ranstam, J. (författare)
Ström, K. (författare)
visa färre...
 (creator_code:org_t)
Elsevier BV, 2006
2006
Engelska.
Ingår i: Chest. - : Elsevier BV. - 0012-3692 .- 1931-3543. ; 130:6, s. 1828-33
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: Home mechanical ventilation (HMV) and long-term oxygen therapy (LTOT) are the two treatment alternatives when treating respiratory insufficiency in patients with kyphoscoliosis. We aimed to study the effect on survival with regard to HMV or LTOT alone in patients with respiratory insufficiency due to kyphoscoliosis. METHODS: Swedish patients with nonparalytic kyphoscoliosis (ie, scoliosis not related to neuromuscular disorders) who started LTOT or HMV between 1996 and 2004 were followed up prospectively until February 14, 2006, with death as the primary outcome. Treatment modality, arterial blood gas levels, the presence of concomitant respiratory diseases, and age were recorded at the onset of treatment. No patient was lost to follow-up. RESULTS: One hundred patients received HMV, and 144 patients received oxygen therapy alone. Patients treated with HMV experienced better survival, even when adjusting for age, gender, concomitant respiratory diseases, and blood gas levels, with a hazard ratio of 0.30 (95% confidence interval, 0.18 to 0.51). CONCLUSION: The survival of patients with kyphoscoliosis receiving HMV was better than that of patients treated with LTOT alone. We suggest HMV and not oxygen therapy alone as the primary therapy for patients with respiratory failure due to kyphoscoliosis, regardless of gender, age, and the occurrence of concomitant respiratory diseases.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Nyckelord

Aged
Aged
80 and over
Confidence Intervals
Female
Follow-Up Studies
*Home Care Services
Hospital-Based
Humans
Kyphosis/*complications/mortality
Long-Term Care
Male
Middle Aged
*Oxygen Inhalation Therapy
Proportional Hazards Models
Prospective Studies
*Respiration
Artificial
Respiratory Insufficiency/mortality/*therapy
Scoliosis/*complications/mortality
Survival Analysis
long-term oxygen therapy
kyphoscoliosis
mechanical ventilation
survival
respiratory failure
treatment
Swedevox
Aged

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

  • Chest (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy